Transgene Market Cap

Transgene has a market cap or net worth of €205.41 million as of April 28, 2026. Its market cap has increased by 153.57% in one year.

Market Cap

205.41M

Enterprise Value

95.61M

Revenue

7.21M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.75

Market Cap Chart

Since March 30, 1998, Transgene's market cap has increased from 151.86M to 205.41M, an increase of 35.26%. That is a compound annual growth rate of 1.08%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	205.41M	-21.86%
Dec 31, 2025	262.87M	192.89%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sensorion	191.73M
Cellectis	252.04M
ABIONYX Pharma	126.65M
MaaT Pharma	110.42M
Innate Pharma	108.47M
Genfit	404.84M
Valneva SE	413.53M
Adocia	90.99M

Market Cap Rankings